-
Product Insights
NewLikelihood of Approval Analysis for Hyperphenylalaninemia
Overview How likely is it that the drugs in Hyperphenylalaninemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperphenylalaninemia Overview Abnormally elevated levels of phenylalanine (PHE) in the blood if >2mg/dl...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XMT-1660 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XMT-1660 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XMT-1660 in Ovarian Cancer Drug Details: XMT-1660 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XMT-1660 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XMT-1660 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XMT-1660 in Solid Tumor Drug Details: XMT-1660 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XMT-1660 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XMT-1660 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XMT-1660 in Endometrial Cancer Drug Details: XMT-1660 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XMT-1660 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XMT-1660 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XMT-1660 in Triple-Negative Breast Cancer (TNBC) Drug Details: XMT-1660...
-
Product Insights
Hematology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hematology Pipeline Market Report Overview Hematology tests evaluate numerous conditions involving blood and its components and the tests that generate results immediately and can be done in a limited resource setting. The hematology pipeline market research report provides comprehensive information about the hematology pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Immunohematology ·      Hematology Reagents ·      Hemostasis Calibrators and Controls ·      ...
-
Company Profile
Tower Semiconductor Ltd – Company Profile
Tower Semiconductor Ltd (Tower Semiconductor) operates as a technology company that manufactures and distributes integrated circuit. The company’s products include process design kits, design flows and IP solutions. It offers services such as design center services, design enablement, process services, customer support and multi-project wafer shuttles services, among others. TowerJazz’s technologies comprise RF and HPA, power management, CMOS image sensor, MEMS and mixed-signal or CMOS. The company caters to consumer, automotive, medical, industrial, aerospace and defense and other industries. It...
Add to Basket -
Product Insights
NewTBG Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our TBG Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include COVID 19 testing kits, nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent...
-
Product Insights
Net Present Value Model: RLYB-212
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model RLYB-212 Drug Details RLYB-212 (Human platelet...